These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25394129)

  • 1. Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users.
    Oprea C; Ianache I; Radoi R; Erscoiu S; Tardei G; Nicolaescu O; Nica M; Calistru P; Ruta S; Ceausu E
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19625. PubMed ID: 25394129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users.
    Oprea C; Ianache I; Calistru PI; Nica M; Ruta S; Smith C; Lipman M
    HIV Med; 2018 May; 19(5):316-323. PubMed ID: 29464834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of tuberculosis and mycobacteriosis among HIV-infected patients--clinical and epidemiological analysis of patients from north-eastern Poland.
    Łucejko M; Grzeszczuk A; Rogalska M; Flisiak R
    Pneumonol Alergol Pol; 2013; 81(6):502-10. PubMed ID: 24142779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
    Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
    Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
    Neaigus A; Miller M; Friedman SR; Des Jarlais DC
    J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.
    Backmund M; Meyer K; Henkel C; Reimer J; Wächtler M; Schütz CG
    Eur Addict Res; 2005; 11(3):138-44. PubMed ID: 15990431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure.
    Ramezani A; Mohraz M; Vahabpour R; Jam S; Banifazl M; Eslamifar A; Mahboudi F; Aghakhani A; Edalat R; Hekmat S
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):269-72. PubMed ID: 18836618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.
    Omland LH; Jepsen P; Weis N; Christensen PB; Laursen AL; Nielsen H; Krarup H; Sørensen HT; Obel N
    J Viral Hepat; 2010 Apr; 17(4):261-8. PubMed ID: 19709359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].
    Erokhin VV; Kornilova ZKh; Alekseeva LP
    Probl Tuberk Bolezn Legk; 2005; (10):20-8. PubMed ID: 16318255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
    García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V
    Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infections and co-morbidities among injecting drug users versus sexually infected patients in Bucharest.
    Manea E; Jipa R; Niculescu I; Benea S; Benea O; Arama V; Hristea A
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19665. PubMed ID: 25397415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.